Journals / Turkish Journal of Endocrinology and Metabolism / 2016 / Cilt: 20 - Sayı: 4

Uygunsuz Tirotropin Sendromlu Hastaların Klinik ve Hormonal Özellikleri

Clinical and Hormonal Characteristics of Patients with Syndrome of Inappropriate Secretion of Thyrotropin

Pages
112–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since incidental pituitary tumors are not rare, presence of an adenoma should not rule out the diagnosis of resistance to thyroid hormone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Normal or elevated thyrotropin (TSH) levels in the presence of elevated thyroxine is defined as syndrome of inappropriate secretion of TSH.
📊
Key Findings & Data:Herein, we present the data of seven patients who were hospitalized for the differential diagnosis of the two clinical entities.Material and Method: Our database was reviewed for patients diagnosed with syndrome of inappropriate secretion of TSH in our hospital between 2010 and 2014.
💡
Conclusion & Impact:Since incidental pituitary tumors are not rare, presence of an adenoma should not rule out the diagnosis of resistance to thyroid hormone.
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: Normal or elevated thyrotropin (TSH) levels in the presence of elevated thyroxine is defined as syndrome of inappropriate secretion of TSH. The two main clinical conditions that can lead to this syndrome are TSH-secreting adenoma (TSHoma) and resistance to thyroid hormone. Establishing the correct diagnosis is crucial in order to decide on the most appropriate treatment option. Herein, we present the data of seven patients who were hospitalized for the differential diagnosis of the two clinical entities.Material and Method: Our database was reviewed for patients diagnosed with syndrome of inappropriate secretion of TSH in our hospital between 2010 and 2014. After exclusion of the other rare causes, seven patients who were hospitalized for the differential diagnosis of TSHoma and resistance to thyroid hormone were included.Results: The final diagnosis was resistance to thyroid hormone in four patients, TSHoma in two and equivocal in one. Two patients diagnosed with TSHoma were operated and had positive staining with TSH. Both of the TSHoma cases had macroadenoma on pituitary magnetic resonance imaging and visual field defect, while two of four patients with resistance to thyroid hormone had microadenoma. Alpha-subunit/TSH molar ratio was above 1 in all patients diagnosed with TSHoma while it exceeded 1 in two patients with the final diagnosis of resistance to thyroid hormone. Thyrotrophin-releasing hormone stimulation test revealed a blunted response in all patients with TSHoma and a positive response in all with resistance to thyroid hormone.Discussion: Differential diagnosis of resistance to thyroid hormone and TSHoma can be a clinical challenge and requires complex hormone testing and imaging methods. Since incidental pituitary tumors are not rare, presence of an adenoma should not rule out the diagnosis of resistance to thyroid hormone.

Özet

Amaç: Bir hastada artmış serum serbest tiroksin varlığında normal veya yüksek tirotropin (TSH) düzeyi uygunsuz TSH sendromu olarak adlandırılır. Bu sendroma yol açabilecek iki önemli hastalık; TSH sekrete eden hipofiz adenomu (TSHoma) ve tiroid hormon direncidir. Ayırıcı tanıyı doğru yapmak, en uygun tedavi seçeneğini belirlemek açısından önemlidir. Burada hospitalize edilerek iki klinik antitenin ayırıcı tanısı yapılan yedi hasta sunulmuştur. Gereç ve Yöntem: 2010-2014 yılları arasında uygunsuz TSH tanısı ile takip edilen hastaların verileri gözden geçirildi. Bulgular: Yedi hastanın dördünde kesin klinik tanı tiroid hormon direnci, iki hastada TSHomaydı. Bir hastada klinik tanı netleştirilemedi. TSHoma tanısı ile takip edilen iki hastada opere oldu ve adenom TSH ile pozitif boyandı. TSHoma olgularının her ikisinde de makroadenom ve görme alanı defekti saptanırken, tiroid hormon direnci olgularının ikisinde de mikroadenom tespit edildi. Alpha-subunit/TSH molar oranı TSHomalı hastaların tümünde ve dirençli hastaların ikisinde birin üzerinde saptandı. Tüm tiroid hormon direnci tanısı konulan hastalarda tirotropin serbestleştirici hormon uyarısına pozitif TSH yanıtı mevcuttu.Tartışma: Tiroid hormon direnci ve TSHoma ayırı tanısı klinisyen için zorlayıcıdır ve kompleks hormonal testler ve görüntüleme yöntemleri gerektirir. İnsidental hipofiz tümörleri sıktır bu nedenle adenom varlığı direnç tanısını dışlamamalıdır.

🔖

Cite This Article

POLAT, Ş. B., AYDIN, C., KAYA, G., SEYREK, F. N. Ç., ERSOY, R., ÇAKIR, B. (2016). Uygunsuz Tirotropin Sendromlu Hastaların Klinik ve Hormonal Özellikleri. Turkish Journal of Endocrinology and Metabolism, Cilt: 20 - Sayı: 4, 112–116. https://ajindex.com/articles/370870

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Portmann L, Gomez F, Flattet A. [Inappropriate TSH: from common etiologies to the rare TSH secreting pituitary adenoma]. Rev Med Suisse. 2012;8:2187- 2191
  2. Akiyoshi F, Okamura K, Fujikawa M, Sato K, Yoshinari M, Mizokami T, Hattori K, Kuwayama A, Takahashi Y, Fujishima M. Difficulty in differentiating thyrotropin secreting pituitary microadenoma from pituitary-selective thyroid hormone resistance accompanied by pituitary incidentaloma. Thyroid. 1996;6:619-625
  3. Lee SH, Kang JG, Hahm MC, Park JH, Kim KM, Lim TW, Kim YR. Anesthetic experience in a clinically euthyroid patient with hyperthyroxinemia and suspected impairment of T4 to T3 conversion: a case report. Korean J Anesthesiol. 2014;67:144-147
  4. Hidaka Y, Tada H, Kashiwai T, Sasaki S, Andoh S, Nakamura H, Amino N. A case of hyperthyroidism due to pituitary resistance to thyroid hormone. Endocr J. 1994;41:339-343
  5. Weiss RE, Refetoff S. Resistance to thyroid hormone. Rev Endocr Metab Disord. 2000;1:97-108
  6. Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol. 2014;10:582-591
  7. Visser WE, van Mullem AA, Visser TJ, Peeters RP. Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management. Clin Endocrinol (Oxf). 2013;79:595-605
  8. Anselmo J, Refetoff S. Regression of a large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine. Thyroid. 2004;14:71-74
  9. Duarte FH, Jallad RS, Salgado LR, Bronstein MD. [TSH-secreting pituitary tumors: two case reports and literature review]. Arq Bras Endocrinol Metabol. 2009;53:1157-1166
  10. Roelfsema F, Kok S, Kok P, Pereira AM, Biermasz NR, Smit JW, Frolich M, Keenan DM, Veldhuis JD, Romijn JA. Pituitary-hormone secretion by thyrotropinomas. Pituitary. 2009;12:200-210
  11. Beck-Peccoz P, Persani L, Mannavola D, Campi I. Pituitary tumours: TSHsecreting adenomas. Best Pract Res Clin Endocrinol Metab. 2009;23:597- 606
  12. Safer JD, Colan SD, Fraser LM, Wondisford FE. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid. 2001;11:281-291
  13. Gurnell M, Rajanayagam O, Barbar I, Jones MK, Chatterjee VK. Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid. 1998;8:679-682
  14. Dutta D, Maisnam I, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Panhypopituitarism with empty sella a sequel of pituitary hyperplasi